Literature DB >> 16311896

Correlates of subjective and functional outcomes in outpatient clinic attendees with schizophrenia and schizoaffective disorder.

Alex Hofer1, Maria A Rettenbacher, Christian G Widschwendter, Georg Kemmler, Martina Hummer, W Wolfgang Fleischhacker.   

Abstract

Outcome in schizophrenia is multidimensional and, thus, consists of clinical,humanitarian, rehabilitative and cost domains. Accordingly, recovery is conceptualized as the ability to function in the community, socially and vocationally, as well as being relatively free of disease-related psychopathology. The present cross-sectional study examined the relationship of premorbid functioning, psychopathology, insight, attitudes toward medication and side-effects, as well as sociodemographic factors with treatment outcomes in terms of quality of life (QOL) and psychosocial functioning among 60 regular attendees of a specialized schizophrenia outpatient clinic. Both insight into the illness as well as attitudes toward treatment indicated satisfactory compliance. Premorbid school and social functioning were positively correlated with actual employment status, and premorbid social functioning was further positively correlated with QOL and global functioning. Attitudes toward treatment were positively associated with global QOL, and with the patients' living situation. Both positive and negative symptoms as well as asthenia were negatively associated with QOL, while cognitive symptoms negatively influenced occupational functioning. Older patients lived independently and/or in a partnership more often, but had a lesser likelihood of competitive employment. Our observations suggest that subjective and functional outcomes in highly compliant patients are mainly predicted by psychopathological symptoms and unchangeable sociodemographic variables.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16311896     DOI: 10.1007/s00406-005-0633-3

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  51 in total

1.  General life satisfaction and domain-specific quality of life in chronic schizophrenic patients.

Authors:  G Kemmler; B Holzner; C Neudorfer; U Meise; H Hinterhuber
Journal:  Qual Life Res       Date:  1997-04       Impact factor: 4.147

2.  Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group.

Authors: 
Journal:  Psychol Med       Date:  1998-05       Impact factor: 7.723

3.  Subjective quality of life in first episode schizophrenia spectrum disorders with comorbid depression.

Authors:  Kang Sim; Rathi Mahendran; Samuel G Siris; Stephan Heckers; Siow Ann Chong
Journal:  Psychiatry Res       Date:  2004-12-15       Impact factor: 3.222

4.  Subjective and external assessments of quality of life in schizophrenia: relationship to insight.

Authors:  M Doyle; S Flanagan; S Browne; M Clarke; D Lydon; C Larkin; E O'Callaghan
Journal:  Acta Psychiatr Scand       Date:  1999-06       Impact factor: 6.392

Review 5.  Patients' subjective experiences on antipsychotic medications: implications for outcome and quality of life.

Authors:  A G Awad; T P Hogan; L N Voruganti; R J Heslegrave
Journal:  Int Clin Psychopharmacol       Date:  1995-09       Impact factor: 1.659

6.  The impact of weight gain on quality of life among persons with schizophrenia.

Authors:  David B Allison; Joan A Mackell; Diana D McDonnell
Journal:  Psychiatr Serv       Date:  2003-04       Impact factor: 3.084

7.  The personal impact of schizophrenia in Europe.

Authors:  Graham Thornicroft; Michele Tansella; Thomas Becker; Martin Knapp; Morven Leese; Aart Schene; José Luis Vazquez-Barquero
Journal:  Schizophr Res       Date:  2004-08-01       Impact factor: 4.939

8.  Five factor model of schizophrenia: replication across samples.

Authors:  J P Lindenmayer; S Grochowski; R B Hyman
Journal:  Schizophr Res       Date:  1995-02       Impact factor: 4.939

9.  Five-year outcome and prognosis in schizophrenia: a report from the London Field Research Centre of the International Pilot Study of Schizophrenia.

Authors:  R Prudo; H M Blum
Journal:  Br J Psychiatry       Date:  1987-03       Impact factor: 9.319

10.  The relationship between positive symptoms and instrumental work functioning in schizophrenia: a 10 year follow-up study.

Authors:  J Meg Racenstein; Martin Harrow; Robyn Reed; Eileen Martin; Ellen Herbener; David L Penn
Journal:  Schizophr Res       Date:  2002-07-01       Impact factor: 4.939

View more
  27 in total

1.  Prediction of community outcome in schizophrenia 1 year after discharge from inpatient treatment.

Authors:  Andreas Wittorf; Georg Wiedemann; Gerhard Buchkremer; Stefan Klingberg
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-11-07       Impact factor: 5.270

2.  Treatment adherence in schizophrenia: a patient-level meta-analysis of combined CATIE and EUFEST studies.

Authors:  Pál Czobor; Richard A Van Dorn; Leslie Citrome; Rene S Kahn; W Wolfgang Fleischhacker; Jan Volavka
Journal:  Eur Neuropsychopharmacol       Date:  2015-04-30       Impact factor: 4.600

3.  The relationship of social function to depressive and negative symptoms in individuals at clinical high risk for psychosis.

Authors:  C M Corcoran; D Kimhy; M A Parrilla-Escobar; V L Cressman; A D Stanford; J Thompson; S Ben David; A Crumbley; S Schobel; H Moore; D Malaspina
Journal:  Psychol Med       Date:  2010-05-06       Impact factor: 7.723

4.  Assessment of functioning and disability in patients with schizophrenia using the WHO Disability Assessment Schedule 2.0 in a large-scale database.

Authors:  Ruey Chen; Tsan-Hon Liou; Kwang-Hwa Chang; Chia-Feng Yen; Hua-Fang Liao; Wen-Chou Chi; Kuei-Ru Chou
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-08-11       Impact factor: 5.270

5.  Family interventions for schizophrenia in Italy: randomized controlled trial.

Authors:  Giuseppe Carrà; Cristina Montomoli; Massimi Clerici; Carlo Lorenzo Cazzullo
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-02       Impact factor: 5.270

6.  Insight, quality of life, and functional capacity in middle-aged and older adults with schizophrenia.

Authors:  Ashley S Roseman; John Kasckow; Ian Fellows; Katerine Osatuke; Thomas L Patterson; Somaia Mohamed; Sidney Zisook
Journal:  Int J Geriatr Psychiatry       Date:  2008-07       Impact factor: 3.485

7.  Symptoms as mediators of the relationship between neurocognition and functional outcome in schizophrenia: a meta-analysis.

Authors:  Joseph Ventura; Gerhard S Hellemann; April D Thames; Vanessa Koellner; Keith H Nuechterlein
Journal:  Schizophr Res       Date:  2009-07-22       Impact factor: 4.939

8.  Determinants of objective and subjective quality of life in first-time-admission schizophrenic patients in Poland: a longitudinal study.

Authors:  Krystyna Górna; Krystyna Jaracz; Filip Rybakowski; Janusz Rybakowski
Journal:  Qual Life Res       Date:  2007-12-28       Impact factor: 4.147

9.  Atypical antipsychotics for older adults: are they safe and effective as we once thought?

Authors:  Dilip V Jeste; Jeanne E Maglione
Journal:  J Comp Eff Res       Date:  2013-07       Impact factor: 1.744

10.  The dilemma of insight into illness in schizophrenia: self- and expert-rated insight and quality of life.

Authors:  A Karow; F-G Pajonk; J Reimer; F Hirdes; C Osterwald; D Naber; S Moritz
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-04       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.